Medicaid coverage
Delaware: what Medicaid covers
Delaware runs an obesity treatment agents class where every agent needs prior authorization. Two preferred products have to be tried before a non-preferred one is approved, which puts Saxenda and the Wegovy tablet behind the Wegovy and Zepbound pens.
| Drug | Position | Criteria |
|---|---|---|
| Semaglutide | Prior authorization | Wegovy pen and Wegovy HD preferred. Wegovy tablets non-preferred. Prior authorization on every agent in the class |
| Tirzepatide | Prior authorization | Zepbound auto-injector and KwikPen both preferred. Prior authorization on every agent in the class |
| Liraglutide | Prior authorization | Saxenda and the generic pen are non-preferred, so two preferred products have to be tried first |
-
Semaglutide Prior authorization
Wegovy pen and Wegovy HD preferred. Wegovy tablets non-preferred. Prior authorization on every agent in the class
-
Tirzepatide Prior authorization
Zepbound auto-injector and KwikPen both preferred. Prior authorization on every agent in the class
-
Liraglutide Prior authorization
Saxenda and the generic pen are non-preferred, so two preferred products have to be tried first
Sources
Every claim above is checked against the primary text, and the date is the day we last opened it.
-
1
2026 Delaware Medicaid Preferred Drug List
Delaware Division of Medicaid and Medical Assistance Primary text read and checked Checked August 25, 2026